Aquestive Therapeutics, Inc. SEC filings AQST
Aquestive Therapeutics, Inc. has 686 filings in SEC EDGAR's recent list, going back to May 14, 2007. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 19, 2026 | Oct 15, 2026 |
| 4 | Insider transaction | Oct 16, 2026 | Oct 15, 2026 |
| 3 | Initial insider ownership | Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 14, 2026 | Oct 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 7, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 7, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 25, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 15, 2026 |
| 144 | Notice of proposed sale | Sep 15, 2026 | — |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| 144 | Notice of proposed sale | Sep 9, 2026 | — |
| 4 | Insider transaction | Sep 8, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 10, 2026 | Aug 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 27, 2026 | — |
| 4 | Insider transaction | Jul 17, 2026 | Jul 15, 2026 |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| 424B3 | Prospectus | Jul 9, 2026 | — |
| EFFECT | Filing | Jul 8, 2026 | — |
| S-3 | Shelf registration | Jun 26, 2026 | — |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 144 | Notice of proposed sale | Jun 15, 2026 | — |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 144 | Notice of proposed sale | May 15, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure
|
May 13, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Mar 7, 2025 |
| 4 | Insider transaction | Apr 13, 2026 | Mar 7, 2025 |
| 4 | Insider transaction | Apr 13, 2026 | Mar 7, 2025 |
| 4 | Insider transaction | Apr 13, 2026 | Mar 7, 2025 |
| 4 | Insider transaction | Apr 13, 2026 | Mar 7, 2025 |
| 4 | Insider transaction | Apr 13, 2026 | Mar 7, 2025 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 20, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 3 | Initial insider ownership | Mar 11, 2026 | Mar 2, 2026 |
| S-8 | Employee stock plan registration | Mar 4, 2026 | — |
| 10-K | Annual report | Mar 4, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Mar 4, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2026 | Jan 30, 2026 |
| S-8 | Employee stock plan registration | Jan 21, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 2, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| 3 | Initial insider ownership | Nov 12, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2025 | Nov 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 144 | Notice of proposed sale | Oct 15, 2025 | — |
| 144 | Notice of proposed sale | Oct 15, 2025 | — |
| 144 | Notice of proposed sale | Oct 15, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 8, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Sep 29, 2025 | Sep 26, 2025 |
| 4 | Insider transaction | Sep 29, 2025 | Sep 26, 2025 |
| 144 | Notice of proposed sale | Sep 29, 2025 | — |
| 144 | Notice of proposed sale | Sep 26, 2025 | — |
| 4 | Insider transaction | Sep 22, 2025 | Sep 19, 2025 |
| 144 | Notice of proposed sale | Sep 19, 2025 | — |
| 4 | Insider transaction | Sep 8, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2025 | Sep 8, 2025 |
| 144 | Notice of proposed sale | Sep 5, 2025 | — |
| 144 | Notice of proposed sale | Sep 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 15, 2025 | Aug 14, 2025 |
| 424B5 | Prospectus supplement | Aug 14, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 14, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 9, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Other events
|
Jul 15, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2025 | May 12, 2025 |
| 3 | Initial insider ownership | May 7, 2025 | Apr 25, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2025 | Mar 10, 2025 |
| 10-K | Annual report | Mar 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 12, 2025 | Feb 12, 2025 |
| S-8 | Employee stock plan registration | Jan 24, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Dec 19, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 2, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Other events
|
Oct 25, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 16, 2024 | Oct 16, 2024 |
| 4/A | Primary document | Oct 2, 2024 | Mar 9, 2024 |
| 4/A | Primary document | Oct 2, 2024 | Mar 9, 2024 |
| 4/A | Primary document | Oct 2, 2024 | Mar 9, 2024 |
| 4/A | Primary document | Oct 2, 2024 | Mar 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 25, 2024 | Jul 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 3/A | Primary document | Jun 12, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 3 | Initial insider ownership | Jun 11, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 8, 2024 | May 7, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AQST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Warren, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1398733
- Former names
- MonoSol Rx, Inc. (until Mar 27, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.